These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 26179919)

  • 21. Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders.
    Hobson GM; Garbern JY
    Semin Neurol; 2012 Feb; 32(1):62-7. PubMed ID: 22422208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pelizaeus-Merzbacher disease.
    Koeppen AH; Robitaille Y
    J Neuropathol Exp Neurol; 2002 Sep; 61(9):747-59. PubMed ID: 12230321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypomyelinating leukodystrophy-associated missense mutant of FAM126A/hyccin/DRCTNNB1A aggregates in the endoplasmic reticulum.
    Miyamoto Y; Torii T; Eguchi T; Nakamura K; Tanoue A; Yamauchi J
    J Clin Neurosci; 2014 Jun; 21(6):1033-9. PubMed ID: 24417797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pelizaeus-Merzbacher Disease: Molecular and Cellular Pathologies and Associated Phenotypes.
    Inoue K
    Adv Exp Med Biol; 2019; 1190():201-216. PubMed ID: 31760646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A severe connatal form of Pelizaeus Merzbacher disease in a Czech boy caused by a novel mutation (725C>A, Ala242Glu) at the 'jimpy(msd) codon' in the PLP gene.
    Seeman P; Paderova K; Benes V; Sistermans EA
    Int J Mol Med; 2002 Feb; 9(2):125-9. PubMed ID: 11786921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant trafficking of a proteolipid protein in a mild Pelizaeus-Merzbacher disease.
    Koizume S; Takizawa S; Fujita K; Aida N; Yamashita S; Miyagi Y; Osaka H
    Neuroscience; 2006 Sep; 141(4):1861-9. PubMed ID: 16844304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Processing of PLP in a model of Pelizaeus-Merzbacher disease/SPG2 due to the rumpshaker mutation.
    McLaughlin M; Barrie JA; Karim S; Montague P; Edgar JM; Kirkham D; Thomson CE; Griffiths IR
    Glia; 2006 May; 53(7):715-22. PubMed ID: 16506223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel pathologic findings in patients with Pelizaeus-Merzbacher disease.
    Laukka JJ; Kamholz J; Bessert D; Skoff RP
    Neurosci Lett; 2016 Aug; 627():222-32. PubMed ID: 27222925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High frequency of GJA12/GJC2 mutations in Turkish patients with Pelizaeus-Merzbacher disease.
    Bilir B; Yapici Z; Yalcinkaya C; Baris I; Carvalho CM; Bartnik M; Ozes B; Eraksoy M; Lupski JR; Battaloglu E
    Clin Genet; 2013 Jan; 83(1):66-72. PubMed ID: 22283455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter mutation is a common variant in GJC2-associated Pelizaeus-Merzbacher-like disease.
    Meyer E; Kurian MA; Morgan NV; McNeill A; Pasha S; Tee L; Younis R; Norman A; van der Knaap MS; Wassmer E; Trembath RC; Brueton L; Maher ER
    Mol Genet Metab; 2011 Dec; 104(4):637-43. PubMed ID: 21959080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.
    Woodward KJ
    Expert Rev Mol Med; 2008 May; 10():e14. PubMed ID: 18485258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel proteolipid protein 1 gene mutation causing classical type Pelizaeus-Merzbacher disease.
    Fukumura S; Adachi N; Nagao M; Tsutsumi H
    Brain Dev; 2011 Sep; 33(8):697-9. PubMed ID: 21177054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel PLP1 mutation further expands the clinical heterogeneity at the locus.
    Hand CK; Bernard G; Dubé MP; Shevell MI; Rouleau GA
    Can J Neurol Sci; 2012 Mar; 39(2):220-4. PubMed ID: 22343157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease.
    Henneke M; Combes P; Diekmann S; Bertini E; Brockmann K; Burlina AP; Kaiser J; Ohlenbusch A; Plecko B; Rodriguez D; Boespflug-Tanguy O; Gärtner J
    Neurology; 2008 Mar; 70(10):748-54. PubMed ID: 18094336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis.
    Garbern JY
    Cell Mol Life Sci; 2007 Jan; 64(1):50-65. PubMed ID: 17115121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel homozygous mutation of GJC2 derived from maternal uniparental disomy in a female patient with Pelizaeus-Merzbacher-like disease.
    Shimojima K; Tanaka R; Shimada S; Sangu N; Nakayama J; Iwasaki N; Yamamoto T
    J Neurol Sci; 2013 Jul; 330(1-2):123-6. PubMed ID: 23684670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GJC2 promoter mutations causing Pelizaeus-Merzbacher-like disease.
    Gotoh L; Inoue K; Helman G; Mora S; Maski K; Soul JS; Bloom M; Evans SH; Goto YI; Caldovic L; Hobson GM; Vanderver A
    Mol Genet Metab; 2014 Mar; 111(3):393-398. PubMed ID: 24374284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disrupted SOX10 regulation of GJC2 transcription causes Pelizaeus-Merzbacher-like disease.
    Osaka H; Hamanoue H; Yamamoto R; Nezu A; Sasaki M; Saitsu H; Kurosawa K; Shimbo H; Matsumoto N; Inoue K
    Ann Neurol; 2010 Aug; 68(2):250-4. PubMed ID: 20695017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neural stem cells restore myelin in a demyelinating model of Pelizaeus-Merzbacher disease.
    Gruenenfelder FI; McLaughlin M; Griffiths IR; Garbern J; Thomson G; Kuzman P; Barrie JA; McCulloch ML; Penderis J; Stassart R; Nave KA; Edgar JM
    Brain; 2020 May; 143(5):1383-1399. PubMed ID: 32419025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and mutational spectrum of Colombian patients with Pelizaeus Merzbacher Disease.
    Velasco Parra HM; Maradei Anaya SJ; Acosta Guio JC; Arteaga Diaz CE; Prieto Rivera JC
    Colomb Med (Cali); 2018 Jun; 49(2):182-187. PubMed ID: 30104812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.